DJ AstraZeneca PLC ADR Falls Monday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ slipped 1.91% to $65.73 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.86% to 42,297.12 and the NASDAQ Composite Index falling 0.38% to 19,088.10.
AstraZeneca PLC ADR closed $21.95 short of its 52-week high ($87.68), which the company achieved on August 30th.
The ADR underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ fell 0.30% to $797.48, Biogen Inc. $(BIIB)$ rose 0.91% to $150.18, and Johnson & Johnson $(JNJ)$ rose 1.70% to $144.47.
Trading volume (7.7 M) eclipsed its 50-day average volume of 6.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 13, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 13, 2025 17:28 ET (22:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.